AL
CNMD icon

ADE LLC’s CONMED CNMD Stock Holding History

ADE LLC’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-150
Closed -$21K – 251
2021
Q2 		$21K Buy
+150
New +$20.5K 0.02% 178

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

ADE LLC's CNMD Position: Q3 2021 in Review

ADE LLC sold out of CONMED (CNMD) in Q3 2021, closing a stake of 150 shares — an estimated $21K sold.

ADE LLC first reported a position in CNMD in Q2 2021 and held it in 1 quarter. The position peaked at $21K in Q2 2021. 262 funds tracked by Wall St. Rank hold CNMD as of Q3 2021.

  • ADE LLC reported no remaining CONMED position as of Q3 2021 after selling out during the quarter.
  • ADE LLC sold 150 CONMED shares in Q3 2021, an estimated $21K.
  • ADE LLC first reported a position in CONMED in Q2 2021 and held it in 1 quarter.
  • ADE LLC's CONMED position peaked at $21K in Q2 2021.
  • 262 funds tracked by Wall St. Rank held CONMED as of Q3 2021.

Based on ADE LLC's 13F filing for Q3 2021, filed 22 Oct 2021.